AR and cancer: They may encompass processes such as expression of constitutively active AR variants [117], ligand-independent activation of AR [118], or expression of gain-of-function p53 mutants, which have been recently demonstrated to induce conversion of fibroblasts to a cancer-associated phenotype that supports increased tumour growth and metastasis [108,119,120].